Many employers and insurers are scaling back coverage and Medicare doesn’t cover the drugs for obesity. Meantime, some big ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
While Ozempic is covered by most health plans, weight loss drugs such as Wegovy are not currently covered by Medicare and other insurance. Don't expect a 20% S&P 500 three-peat this year ...
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
Popular weight-loss drugs such as Ozempic, Wegovy and Zepbound are a growing ... and North Carolina adding coverage in August. Coverage under Medicare remains prohibited while most large employer ...
But unprecedented demand has made it difficult for the companies to manufacture sufficient supplies, even though Medicare and some ... about its version of Wegovy was omitted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback